These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28315856)

  • 1. An update on HLA alleles associated with adverse drug reactions.
    Fricke-Galindo I; LLerena A; López-López M
    Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
    Wang Q; Mei H; Zhang YL; Pan XC; Tan W; Chao L
    Yao Xue Xue Bao; 2013 Jun; 48(6):799-808. PubMed ID: 23984511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of hypersensitivity drug reactions.
    Negrini S; Becquemont L
    Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigens and drug hypersensitivity.
    Chung WH; Hung SI; Chen YT
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
    Borroni RG
    G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic information derived from analysis of HLA alleles.
    Gatanaga H; Honda H; Oka S
    Pharmacogenomics; 2008 Feb; 9(2):207-14. PubMed ID: 18370849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA alleles and drug hypersensitivity reactions.
    Profaizer T; Eckels D
    Int J Immunogenet; 2012 Apr; 39(2):99-105. PubMed ID: 22136512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotyping for severe drug hypersensitivity.
    Karlin E; Phillips E
    Curr Allergy Asthma Rep; 2014 Mar; 14(3):418. PubMed ID: 24429903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions].
    Xiong Y; Zhang W; Chen X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 39(7):749-57. PubMed ID: 25080918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
    Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
    Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA Association with Drug-Induced Adverse Reactions.
    Fan WL; Shiao MS; Hui RC; Su SC; Wang CW; Chang YC; Chung WH
    J Immunol Res; 2017; 2017():3186328. PubMed ID: 29333460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactions.
    Ramsbottom KA; Carr DF; Jones AR; Rigden DJ
    Mol Immunol; 2018 Sep; 101():488-499. PubMed ID: 30125869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls.
    Daly AK
    Curr Drug Metab; 2014 Feb; 15(2):196-201. PubMed ID: 24694233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.
    Gerogianni K; Tsezou A; Dimas K
    Mol Diagn Ther; 2018 Jun; 22(3):297-314. PubMed ID: 29564734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.
    Negrini S; Becquemont L
    Pharmacogenomics; 2017 Oct; 18(15):1441-1457. PubMed ID: 29017379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA associations and clinical implications in T-cell mediated drug hypersensitivity reactions: an updated review.
    Cheng CY; Su SC; Chen CH; Chen WL; Deng ST; Chung WH
    J Immunol Res; 2014; 2014():565320. PubMed ID: 24901010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
    White KD; Chung WH; Hung SI; Mallal S; Phillips EJ
    J Allergy Clin Immunol; 2015 Aug; 136(2):219-34; quiz 235. PubMed ID: 26254049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics of allopurinol--making an old drug safer.
    Lam MP; Yeung CK; Cheung BM
    J Clin Pharmacol; 2013 Jul; 53(7):675-9. PubMed ID: 23381951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.